Multidose BCG Protects Against COVID-19 in At-Risk Individuals
Efficacy of 92 percent found among at-risk COVID-19-unvaccinated individuals with type 1 diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.